Journal of Mid-life Health Journal of Mid-life Health
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission | Subscribe | Advertise Users Online: 25  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 

Year : 2021  |  Volume : 12  |  Issue : 2  |  Page : 108-115

Evaluation of the efficacy and safety of rheum rhaponticum root extract (err 731) for menopausal symptoms in perimenopausal indian women: An interim analysis

1 Department of Obstetrics and Gynecology, Dr. Shah Maternity and Nursing Home, Ahmedabad, Gujarat, India
2 Department of Obstetrics and Gynecology, Bombay Maternity and Surgical Hospital, Surat, Gujarat, India
3 Department of Obstetrics and Gynecology, JJ Hospital, Hyderabad, Telangana, India
4 Department of Obstetrics and Gynecology, St. Thomas Hospital, Chennai, India
5 Department of Obstetrics and Gynecology, Sampreeti Hospital, Sivasagar, Assam, India
6 Department of Obstetrics and Gynecology, Jain Hospital, Varanasi, Uttar Pradesh, India
7 Department of Obstetrics and Gynecology, Anugraha Nursing Home, Bengaluru, Karnataka, India
8 Biniwale Clinic, Pune, Maharashtra, India
9 Consultation Clinic, Indore, Madhya Pradesh, India
10 Department of Obstetrics and Gynecology, Ridhorkar Hospital, Nagpur, Maharashtra, India
11 Ganga Women and Child Center, Coimbatore, Tamil Nadu, India
12 Department of Obstetrics and Gynecology, Life Care Hospital, Indore, Madhya Pradesh, India

Correspondence Address:
Jignesh Shah
Dr.Shah Maternity and Nursing Home, Ahmedabad, Gujarat
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jmh.jmh_86_21

Rights and Permissions

Background: Hormonal therapy for menopause has been found to be the most efficacious treatment, but it may be associated with adverse effects in some of the women. Rheum rhaponticum root extract (”ERr 731”), which is available worldwide, is a natural, reliable, effective, and well-tolerated remedy for women in perimenopausal women with menopausal symptoms (MSs), but there is no Indian study demonstrating its efficacy, safety, and tolerability till date. Objective: This study aimed to evaluate the efficacy and safety of ERr 731 in alleviating MSs in perimenopausal Indian women. Patients and Methods: In this open-labeled prospective study, 129 perimenopausal women were treated with tablet containing 4 mg of Rr dried root extract once daily for 12 weeks. The Menopause Rating Scale (MRS) II score, endometrial thickness (ET), blood pressure, glycemic status, lipid profile, and high-sensitivity C-reactive protein (hs-CRP) level were periodically assessed and compared. Results: A significant reduction (67% by 12th week) in the mean MRS II score was observed from baseline till the end of 12 weeks (18.1; 95% confidence interval [CI]: 17.0–19.2; P < 0.001). A monotonic reduction in the mean total MRS II score over time was found (1.51 units/week; 95% CI: 1.42–1.60 units/week; P < 0.001) noticeable. There was a reduction in the mean ET from baseline till the end of 12 weeks, although the change was not significant. There were significant reductions in the mean fasting (6.3 mg/dl; 95% CI: 1.7–11.0 mg/dl; P = 0.008) and postprandial (6.3 mg/dl; 95% CI: 1.0–11.7; P = 0.021) blood glucose levels and glycated hemoglobin level (0.30%; 95% CI: 0.085–0.520; P = 0.007) at 12 weeks. No significant changes were noted in terms of blood pressure, lipid profile, and hs-CRP level. The drug was found to be safe. Conclusion: ERr 731 was well tolerated and was found to be efficacious and safe in alleviating MSs in Indian perimenopausal women.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal